Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betaseron vs Copaxone in RRMS and CIS (BECOME)
NCT00176592Phase 4Completed
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Jan 2003
- Primary completion
- Jan 2007
- Modality
- Interferons
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of interferon beta in multiple sclerosis (MS) and clinically isolated syndrome (CIS) (2 arms), sponsored by University of Medicine and Dentistry of New Jersey. Primary endpoint: Number of Combined Active Lesions (CAL) at 2 years. Started Jan 2003; status: completed.
02
Drugs
interferon beta
03
Conditions
multiple sclerosis (MS)clinically isolated syndrome (CIS)
Beyond the preview
Go deeper on NCT00176592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00176592.